These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 3095121

  • 21. Ifosfamide and mesna at high doses for the treatment of cancer of the cervix: a GETLAC study.
    Cervellino JC, Araujo CE, Pirisi C, Sanchez O, Brosto M, Rossi R.
    Cancer Chemother Pharmacol; 1990; 26 Suppl():S1-3. PubMed ID: 2112052
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Combination chemotherapy with adriamycin, ifosfamide and mesna in extensive-stage non-small cell bronchogenic carcinoma.
    Matthiessen W, Stempinski E, Göbel D, Thalmann U.
    Cancer Treat Rev; 1983 Sep; 10 Suppl A():121-3. PubMed ID: 6414688
    [No Abstract] [Full Text] [Related]

  • 28. [Epileptic seizures and treatment with ifosfamide-mesna].
    Somma-Mauvais H, Farisse P, Viallat JR.
    Rev Neurol (Paris); 1994 Sep; 150(4):307-8. PubMed ID: 7863185
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Ifosfamide and Mesna in advanced malignancies.
    Li GC, Brock N, Li JQ, Guan ZZ, He YJ.
    Chin Med J (Engl); 1988 Mar; 101(3):213-20. PubMed ID: 3136996
    [No Abstract] [Full Text] [Related]

  • 31. Central nervous system toxicity following the treatment of pediatric patients with ifosfamide/mesna.
    Pratt CB, Green AA, Horowitz ME, Meyer WH, Etcubanas E, Douglass E, Hayes FA, Thompson E, Wilimas J, Igarashi M.
    J Clin Oncol; 1986 Aug; 4(8):1253-61. PubMed ID: 3090210
    [Abstract] [Full Text] [Related]

  • 32. Experience with 24-h infusions of ifosfamide/mesna in small cell lung cancer.
    Cantwell BM, Harris AL, Bozzino JM.
    Cancer Chemother Pharmacol; 1986 Aug; 18 Suppl 2():S29. PubMed ID: 3028660
    [Abstract] [Full Text] [Related]

  • 33. Ifosfamide plus mesna with and without adriamycin in soft tissue sarcoma.
    Wiltshaw E, Westbury G, Harmer C, McKinna A, Fisher C.
    Cancer Chemother Pharmacol; 1986 Aug; 18 Suppl 2():S10-2. PubMed ID: 3102088
    [Abstract] [Full Text] [Related]

  • 34. The protective effect of 2-mercapto-ethane sulfonate (MESNA) on hemorrhagic cystitis induced by high-dose ifosfamide treatment tested by a randomized crossover trial.
    Sakurai M, Saijo N, Shinkai T, Eguchi K, Sasaki Y, Tamura T, Sano T, Suemasu K, Jett JR.
    Jpn J Clin Oncol; 1986 Jun; 16(2):153-6. PubMed ID: 3090314
    [Abstract] [Full Text] [Related]

  • 35. Ifosfamide and mesna: marginally active in patients with advanced carcinoma of the pancreas.
    Ajani JA, Abbruzzese JL, Goudeau P, Faintuch JS, Yeomans AC, Boman BM, Nicaise C, Levin B.
    J Clin Oncol; 1988 Nov; 6(11):1703-7. PubMed ID: 3141592
    [Abstract] [Full Text] [Related]

  • 36. Treatment of advanced soft tissue and osteogenic sarcomas with continuous infusion of ifosfamide and mesna.
    Klein HO, Dias Wickramanayake P, Coerper C, Christian E.
    Cancer Chemother Pharmacol; 1986 Nov; 18 Suppl 2():S19. PubMed ID: 3102091
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Cyclophosphamide and ifosfamide: role of uroprotective agents.
    Williams SD, Munshi N, Einhorn LH, Loehrer PJ.
    Cancer Invest; 1990 Nov; 8(2):269. PubMed ID: 2119246
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.